Millar, David G.
Ramjiawan, Rakesh R.
Kawaguchi, Kosuke
Gupta, Nisha
Chen, Jiang
Zhang, Songfa
Nojiri, Takashi
Ho, William W. http://orcid.org/0000-0002-1755-833X
Aoki, Shuichi
Jung, Keehoon
Chen, Ivy
Shi, Feng
Heather, James M. http://orcid.org/0000-0002-1783-5181
Shigeta, Kohei http://orcid.org/0000-0003-1596-4200
Morton, Laura T.
Sepulveda, Sean
Wan, Li
Joseph, Ricky
Minogue, Eleanor
Khatri, Ashok
Bardia, Aditya
Ellisen, Leif W.
Corcoran, Ryan B. http://orcid.org/0000-0001-8173-5778
Hata, Aaron N.
Pai, Sara I.
Jain, Rakesh K. http://orcid.org/0000-0001-7571-3548
Fukumura, Dai http://orcid.org/0000-0002-9505-4444
Duda, Dan G.
Cobbold, Mark http://orcid.org/0000-0001-8931-4142
Article History
Received: 11 April 2019
Accepted: 27 December 2019
First Online: 10 February 2020
Competing interests
: R.K.J. received an honorarium from Amgen and consultant fees from Ophthotech, SPARC, SynDevRx and XTuit. R.K.J. owns equity in Enlight, SPARC and SynDevRx, and serves on the Board of Directors of XTuit and Boards of Trustees of Tekla Healthcare Investors, Tekla Life Sciences Investors, Tekla Healthcare Opportunities Fund and Tekla World Healthcare Fund. D.G.D. received consultant fees from Bayer and BMS and has research grants from Bayer, Merrimack, Leap, Exelixis and BMS. M.C. and D.G.M. are named inventors on patent application no. WO 2012/123755, which is licensed to Revitope Oncology. D.G.M. and M.C. own equity in Revitope Oncology. M.C. holds equity in Gritstone Oncology. M.C. received consultant fees from Merck Laboratories. M.C. is now an employee of AstraZeneca.